Detalles de la búsqueda
1.
A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.
Pharmacotherapy
; 28(7): 932-8, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18576908
2.
Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.
Pharmacotherapy
; 28(7): 913-9, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18576906
3.
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Pharmacotherapy
; 28(3): 323-30, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18294112
4.
Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin.
J Cardiovasc Pharmacol
; 51(6): 605-10, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18520949
5.
Multicenter evaluation of vancomycin dosing: emphasis on obesity.
Am J Med
; 121(6): 515-8, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18501233
6.
A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia.
J Clin Lipidol
; 1(6): 634-9, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21291706
7.
Acute elevation of triglycerides after initiation of fosamprinavir/ritonavir in an HIV-negative patient with baseline hypertriglyceridemia.
J Clin Lipidol
; 2(5): 398-400, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21291769
Resultados
1 -
7
de 7
1
Próxima >
>>